The publication “BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells” is on the cover of Blood Journal.
The publication “BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells” is on the cover of Blood Journal.
Intestinal fibroblast heterogeneity: unifying RNA-seq studies and introducing consensus-driven nomenclature. Neda Glisovic, Aleksandra Chikina, Noémie Robil, Sonia Lameiras, Reda Bouras, Danijela Matic Vignjevic J Cell Sci. 2025 Oct 31 Pubmed
Heterozygous pathogenic variants in the splicing factor SF1 lead to a large spectrum of neurodevelopmental disorders. Johnny Bou-Rouphael, Auriane Cospain, Thomas Courtin, Boris Keren, Corentine Marie, Marion Lesieur-Sebellin, Delphine Heron, Jean-Madeleine de Sainte Agathe, Solveig Read more…
DHX9 helicase impacts on splicing decisions by modulating U2 snRNP recruitment in Ewing sarcoma cells Valentina Frezza, Lidia Chellini, Veronica Riccioni, Davide Bonvissuto, Ramona Palombo, Maria Paola Paronetto Nucleic Acids Res. 2025 Feb 14 Pubmed